FDA Strengthens Warning on Powerful Antibiotics | NECN

FDA Strengthens Warning on Powerful Antibiotics

Fluoroquinolones can cause serious and sometimes permanent side-effects

    processing...

    NEWSLETTERS

    Getty Images
    In this file photo, bottles of Cipro are stocked at the University of California Los Angeles Medical Center, October 19, 2001 in Los Angeles, CA. The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics called fluoroquinolones, which includes Cipro, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections.

    The Food and Drug Administration strengthened warnings on a class of antibiotics, calling it too strong to be used for sinus infections, bronchitis and simple urinary tract infections.

    Fluoroquinolones, which include levofloxacin (as known as Levaquin) and ciprofloxacin (Cipro), can cause serious and sometimes permanent side-effects, NBC News reported.

    "While these drugs are effective in treating serious bacterial infections, an FDA safety review found that both oral and injectable fluoroquinolones are associated with disabling side effects involving tendons, muscles, joints, nerves and the central nervous system," the agency said in a statement.

    The drugs are worthwhile to use for potentially fatal infections such as plague, anthrax and some types of bacterial pneumonia but not for the more minor stuff, FDA added.